The role of proteases in epithelial-to-mesenchymal cell transitions in cancer

No abstract is available for this paper.

• Publication year

  2019

• Venue

  Cancer Metastasis Review

• Publication date

  2019-09-01

• Fields of study

  Biology, Medicine

• Identifiers
  DOI 10.1007/s10555-019-09808-2PMID 31482486
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Author Correction: The role of sentrin-specific protease 2 substrate recognition in TGF-β-induced tumorigenesis

  2020cited by this paper
• Cathepsin B Is Upregulated and Mediates ECM Degradation in Colon Adenocarcinoma HT29 Cells Overexpressing Snail

  2019cited by this paper
• USP5 promotes epithelial-mesenchymal transition by stabilizing SLUG in hepatocellular carcinoma

  2019cited by this paper
• Cathepsin L activated by mutant p53 and Egr-1 promotes ionizing radiation-induced EMT in human NSCLC

  2019cited by this paper
• Non-redundant functions of EMT transcription factors

  2019cited by this paper
• EMT Transition States during Tumor Progression and Metastasis.

  2019cited by this paper
• Membrane-Anchored Serine Proteases and Protease-Activated Receptor-2-Mediated Signaling: Co-Conspirators in Cancer Progression.

  2019cited by this paper
• Recent advances in understanding the roles of matrix metalloproteinases in tumour invasion and metastasis

  2019cited by this paper
• Acquisition of a hybrid E/M state is essential for tumorigenicity of basal breast cancer cells

  2019cited by this paper
• Cysteine Cathepsins and Their Extracellular Roles: Shaping the Microenvironment

  2019cited by this paper
• The lysosome as a cellular centre for signalling, metabolism and quality control

  2019cited by this paper
• The role of lysosomal cysteine cathepsins in NLRP3 inflammasome activation.

  2019cited by this paper
• Cysteine cathepsins: Their biological and molecular significance in cancer stem cells.

  2018cited by this paper
• Tumor microenvironment and noncoding RNAs as co‐drivers of epithelial–mesenchymal transition and cancer metastasis

  2018cited by this paper
• USP10 regulates the stability of the EMT-transcription factor Slug/SNAI2.

  2018cited by this paper
• Matrix Metalloproteinase Inhibitors in Cancer Therapy: Turning Past Failures Into Future Successes

  2018cited by this paper
• Transforming growth factor‐β, matrix metalloproteinases, and urokinase‐type plasminogen activator interaction in the cancer epithelial to mesenchymal transition

  2018cited by this paper
• ADAM9 mediates the interleukin-6-induced Epithelial-Mesenchymal transition and metastasis through ROS production in hepatoma cells.

  2018cited by this paper
• Identification of the tumour transition states occurring during EMT

  2018cited by this paper
• ADAM12 induces EMT and promotes cell migration, invasion and proliferation in pituitary adenomas via EGFR/ERK signaling pathway.

  2018cited by this paper
• Ubiquitin‑specific protease 7 promotes osteosarcoma cell metastasis by inducing epithelial‑mesenchymal transition.

  2018cited by this paper
• Cysteine cathepsins in extracellular matrix remodeling: Extracellular matrix degradation and beyond.

  2018cited by this paper
• MMP14 empowers tumor‐initiating breast cancer cells under hypoxic nutrient‐depleted conditions

  2018cited by this paper
• Inhibition of Ubiquitin-Specific Proteases as a Novel Anticancer Therapeutic Strategy

  2018cited by this paper
• Knockdown of TMPRSS3 inhibits gastric cancer cell proliferation, invasion and EMT via regulation of the ERK1/2 and PI3K/Akt pathways.

  2018cited by this paper
• The SUMO System and TGFβ Signaling Interplay in Regulation of Epithelial-Mesenchymal Transition: Implications for Cancer Progression

  2018cited by this paper
• The role of sentrin-specific protease 2 substrate recognition in TGF-β-induced tumorigenesis

  2018cited by this paper
• Snail collaborates with EGR-1 and SP-1 to directly activate transcription of MMP 9 and ZEB1

  2017cited by this paper
• Role of protease and protease inhibitors in cancer pathogenesis and treatment.

  2017cited by this paper
• Cysteine cathepsins B and X promote epithelial-mesenchymal transition of tumor cells.

  2017cited by this paper
• The role of type II transmembrane serine protease‐mediated signaling in cancer

  2017cited by this paper
• Inherited diseases caused by mutations in cathepsin protease genes

  2017cited by this paper
• Hypoxia induces epithelial-mesenchymal transition in colorectal cancer cells through ubiquitin-specific protease 47-mediated stabilization of Snail: A potential role of Sox9

  2017cited by this paper
• Role of matrix metalloproteinase-9 in transforming growth factor-β1-induced epithelial–mesenchymal transition in esophageal squamous cell carcinoma

  2017cited by this paper
• An activated form of ADAM10 is tumor selective and regulates cancer stem-like cells and tumor growth

  2016cited by this paper
• Epithelial-mesenchymal transition in tissue repair and fibrosis

  2016cited by this paper
• Cathepsin L upregulation-induced EMT phenotype is associated with the acquisition of cisplatin or paclitaxel resistance in A549 cells

  2016cited by this paper
• Stability of the hybrid epithelial/mesenchymal phenotype

  2016cited by this paper
• Membrane type 1-matrix metalloproteinase induces epithelial-to-mesenchymal transition in esophageal squamous cell carcinoma: Observations from clinical and in vitro analyses

  2016cited by this paper
• Regulation of the TGF-β pathway by deubiquitinases in cancer.

  2016cited by this paper
• MT1-MMP Activation of TGF-β Signaling Enables Intercellular Activation of an Epithelial-mesenchymal Transition Program in Cancer.

  2016cited by this paper
• Reciprocal activation between MMP-8 and TGF-β1 stimulates EMT and malignant progression of hepatocellular carcinoma.

  2016cited by this paper
• Proteases in cancer drug delivery.

  2016cited by this paper
• Targeting the Nuclear Cathepsin L CCAAT Displacement Protein/Cut Homeobox Transcription Factor-Epithelial Mesenchymal Transition Pathway in Prostate and Breast Cancer Cells with the Z-FY-CHO Inhibitor

  2016cited by this paper
• The ubiquitin ligase Smurf2 suppresses TGFβ-induced epithelial–mesenchymal transition in a sumoylation-regulated manner

  2015cited by this paper
• Lysosomal cysteine peptidases - Molecules signaling tumor cell death and survival.

  2015cited by this paper
• Deubiquitinases and the new therapeutic opportunities offered to cancer

  2015cited by this paper
• Downregulation of cathepsin L suppresses cancer invasion and migration by inhibiting transforming growth factor‑β‑mediated epithelial‑mesenchymal transition.

  2015cited by this paper
• Cysteine cathepsins: their role in tumor progression and recent trends in the development of imaging probes

  2015cited by this paper
• Snail1-induced partial epithelial-to-mesenchymal transition drives renal fibrosis in mice and can be targeted to reverse established disease

  2015cited by this paper
• Deubiquitinases (DUBs) and DUB inhibitors: a patent review

  2015cited by this paper
• Cysteine cathepsin proteases: regulators of cancer progression and therapeutic response

  2015cited by this paper
• The Disintegrin and Metalloprotease ADAM12 Is Associated with TGF-β-Induced Epithelial to Mesenchymal Transition

  2015influential reference
• Lysosomal protein turnover contributes to the acquisition of TGFβ-1 induced invasive properties of mammary cancer cells

  2015cited by this paper
• TMPRSS4 facilitates epithelial-mesenchymal transition of hepatocellular carcinoma and is a predictive marker for poor prognosis of patients after curative resection

  2015cited by this paper
• HtrA1 regulates epithelial-mesenchymal transition in hepatocellular carcinoma.

  2015cited by this paper
• Stemness of the hybrid Epithelial/Mesenchymal State in Breast Cancer and Its Association with Poor Survival

  2015cited by this paper
• Oncogenic roles of EMT-inducing transcription factors

  2014cited by this paper
• The androgen-regulated protease TMPRSS2 activates a proteolytic cascade involving components of the tumor microenvironment and promotes prostate cancer metastasis.

  2014cited by this paper
• Biased Signaling of Protease-Activated Receptors

  2014cited by this paper
• Proteases as activators for cytotoxic prodrugs in antitumor therapy.

  2014cited by this paper
• Shedding of c-Met is regulated by crosstalk between a G-protein coupled receptor and the EGF receptor and is mediated by a TIMP-3 sensitive metalloproteinase

  2014cited by this paper
• Remodelling the extracellular matrix in development and disease

  2014cited by this paper
• Endo-lysosomal proteases in antigen presentation.

  2014cited by this paper
• Pericellular proteolysis in cancer

  2014cited by this paper
• Matrix metalloproteinase-19 promotes metastatic behavior in vitro and is associated with increased mortality in non-small cell lung cancer.

  2014cited by this paper
• Membrane Type 1 Matrix Metalloproteinase induces an epithelial to mesenchymal transition and cancer stem cell-like properties in SCC9 cells

  2013cited by this paper
• Proteases in Cancer: Significance for Invasion and Metastasis

  2013cited by this paper
• Cathepsins mediate tumor metastasis.

  2013cited by this paper
• Tumour heterogeneity and cancer cell plasticity

  2013cited by this paper
• Lysosomal cell death at a glance

  2013cited by this paper
• Extracellular matrix proteins regulate epithelial-mesenchymal transition in mammary epithelial cells.

  2013influential reference
• Downregulation of Serine Protease HTRA1 Is Associated with Poor Survival in Breast Cancer

  2013cited by this paper
• Down-Regulation of HtrA1 Activates the Epithelial-Mesenchymal Transition and ATM DNA Damage Response Pathways

  2012influential reference
• USP15 stabilizes TGF-β receptor I and promotes oncogenesis through the activation of TGF-β signaling in glioblastoma

  2012cited by this paper
• The mechanism of OTUB1 inhibition of ubiquitination

  2012cited by this paper
• USP4 is regulated by AKT phosphorylation and directly deubiquitylates TGF-β type I receptor

  2012cited by this paper
• Ectodomain shedding and ADAMs in development

  2012cited by this paper
• To differentiate or not — routes towards metastasis

  2012cited by this paper
• Matrix compliance regulates Rac1b localization, NADPH oxidase assembly, and epithelial–mesenchymal transition

  2012cited by this paper
• Protease signalling: the cutting edge

  2012cited by this paper
• Direct targeting of Sec23a by miR-200s influences cancer cell secretome and promotes metastatic colonization

  2011cited by this paper
• The Deubiquitinase CYLD Targets Smad7 Protein to Regulate Transforming Growth Factor β (TGF-β) Signaling and the Development of Regulatory T Cells

  2011cited by this paper
• Cancer invasion and the microenvironment: plasticity and reciprocity.

  2011cited by this paper
• δEF1 promotes osteolytic metastasis of MDA-MB-231 breast cancer cells by regulating MMP-1 expression.

  2011cited by this paper
• Tumor metastasis: molecular insights and evolving paradigms.

  2011cited by this paper
• Overexpression of Cathepsin Z Contributes to Tumor Metastasis by Inducing Epithelial-Mesenchymal Transition in Hepatocellular Carcinoma

  2011cited by this paper
• β-catenin/TCF4 complex induces the epithelial-to-mesenchymal transition (EMT)-activator ZEB1 to regulate tumor invasiveness

  2011cited by this paper
• Tumor heterogeneity: causes and consequences.

  2010cited by this paper
• Deficiency for the cysteine protease cathepsin L promotes tumor progression in mouse epidermis

  2010cited by this paper
• Matrix metalloproteinases: regulators of the tumor microenvironment.

  2010cited by this paper
• Macrophage matrix metalloproteinase-9 mediates epithelial-mesenchymal transition in vitro in murine renal tubular cells.

  2010cited by this paper
• ERK2 but not ERK1 induces epithelial-to-mesenchymal transformation via DEF motif-dependent signaling events.

  2010cited by this paper
• FAM/USP9x, a deubiquitinating enzyme essential for TGFbeta signaling, controls Smad4 monoubiquitination.

  2009cited by this paper
• p110 CUX1 Homeodomain Protein Stimulates Cell Migration and Invasion in Part through a Regulatory Cascade Culminating in the Repression of E-cadherin and Occludin*

  2009cited by this paper
• Role of ADAMs in Cancer Formation and Progression

  2009cited by this paper
• Type II transmembrane serine proteases in cancer and viral infections.

  2009cited by this paper
• Epithelial-mesenchymal transitions in development and disease.

  2009cited by this paper
• EMT, the cytoskeleton, and cancer cell invasion

  2009cited by this paper
• Disruption of E-cadherin by matrix metalloproteinase directly mediates epithelial-mesenchymal transition downstream of transforming growth factor-beta1 in renal tubular epithelial cells.

  2009cited by this paper

• Yi Gong San inhibits tumor immune escape by sensitizing colorectal cancer stem cells via the NF-κB pathway

  2025cites this paper
• Innovative Approaches to EMT-Related Biomarker Identification in Breast Cancer: Multi-Omics and Machine Learning Methods

  2025cites this paper
• Non-oncologic to oncologic drug: A systematic review of drug repurposing in cancer

  2025cites this paper
• Comprehensive analysis of mutational features of colorectal cancer and multiple primary cancers including colorectal component: Data from the Cancer Genome Atlas

  2024cites this paper
• Inflammaging: Expansion of Molecular Phenotype and Role in Age-Associated Female Infertility

  2024cites this paper
• ENZYMATIC ACTIVITY OF HIV-1 PROTEASE DEFINES MIGRATION OF TUMOR CELLS IN VITRO AND ENHANCES THEIR METASTATIC ACTIVITY IN VIVO.

  2024cites this paper
• Description of an activity-based enzyme biosensor for lung cancer detection

  2024cites this paper
• Compensational role between cathepsins.

  2024cites this paper
• The Significance of Epithelial Mesenchymal Transition (EMT) in Cancer Metastasis

  2024cites this paper
• Beneficial and Safety Properties of a Bacteriocinogenic and Putative Probiotic Latilactobacillus sakei subsp. sakei 2a Strain

  2024cites this paper
• The roles of proteases in prostate cancer

  2023cites this paper
• Application of functional peptides in the electrochemical and optical biosensing of cancer biomarkers.

  2023cites this paper
• Forkhead box L2 is a target of miR‐133b and plays an important role in the pathogenesis of non‐small cell lung cancer

  2023cites this paper
• Dipeptide-Derived Alkynes as Potent and Selective Irreversible Inhibitors of Cysteine Cathepsins

  2023cites this paper
• TMPRSS4, a type II transmembrane serine protease, as a potential therapeutic target in cancer

  2023cites this paper
• Recent Advances in Targeting the Urokinase Plasminogen Activator with Nanotherapeutics.

  2023cites this paper
• RETRACTED ARTICLE: IL-1RA inhibits esophageal carcinogenesis and lymphangiogenesis via downregulating VEGF-C and MMP9

  2023cites this paper
• Serine protease inhibitors decrease metastasis in prostate, breast, and ovarian cancers

  2023cites this paper
• Insights into the Tumor Microenvironment—Components, Functions and Therapeutics

  2023cites this paper
• Epithelial to mesenchymal transition during mammalian neural crest cell delamination.

  2022cites this paper
• MicroRNA miR-331-3p suppresses osteosarcoma progression via the Bcl-2/Bax and Wnt/β-Catenin signaling pathways and the epithelial-mesenchymal transition by targeting N-acetylglucosaminyltransferase I (MGAT1)

  2022cites this paper
• LINC00313 regulates the metastasis of testicular germ cell tumors through epithelial-mesenchyme transition and immune pathways

  2022cites this paper
• Discovery of a Conditionally Activated IL-2 that Promotes Antitumor Immunity and Induces Tumor Regression

  2022cites this paper
• Ultrasound-Based Molecular Imaging of Tumors with PTPmu Biomarker-Targeted Nanobubble Contrast Agents

  2021cites this paper
• The Tumor Proteolytic Landscape: A Challenging Frontier in Cancer Diagnosis and Therapy

  2021cites this paper
• Expression of protease activated receptor-2 is reduced in renal cell carcinoma biopsies and cell lines

  2021cites this paper
• Substrate-biased activity-based probes identify proteases that cleave receptor CDCP1

  2021cites this paper
• Proteases Regulate Cancer Stem Cell Properties and Remodel Their Microenvironment

  2021cites this paper
• Linc00261 inhibits metastasis and the WNT signaling pathway of pancreatic cancer by regulating a miR-552-5p/FOXO3 axis

  2020cites this paper
• KLF7: a new candidate biomarker and therapeutic target for high-grade serous ovarian cancer

  2020cites this paper
• Important players in carcinogenesis as potential targets in cancer therapy: an update

  2020cites this paper
• Cathepsin V Mediates the Tazarotene-induced Gene 1-induced Reduction in Invasion in Colorectal Cancer Cells

  2020cites this paper
• Metastasis: crosstalk between tissue mechanics and tumour cell plasticity

  2020cites this paper
• Overexpression of DDR1 Promotes Migration, Invasion, Though EMT-Related Molecule Expression and COL4A1/DDR1/MMP-2 Signaling Axis

  2020cites this paper
• Bioinformatics and Molecular Insights to Anti-Metastasis Activity of Triethylene Glycol Derivatives

  2020cites this paper
• Ginsenoside Rg3 Inhibits the Growth of Osteosarcoma and Attenuates Metastasis through the Wnt/β-Catenin and EMT Signaling Pathway

  2020cites this paper
• SPANXN2 functions a cell migration inhibitor in testicular germ cell tumor cells

  2020cites this paper
• EMT-related gene expression is positively correlated with immunity and may be derived from stromal cells in osteosarcoma

  2020cites this paper